Nasus Pharma Ltd Debt Conversion, Converted Instrument, Amount
Nasus Pharma Ltd (NSRX) had Debt Conversion, Converted Instrument, Amount of $2.00 million as of 2024-08-28, per its 20-F filed 2026-03-25.
Financial Statements › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2026-03-25
- 2024-08-28: Debt Conversion, Converted Instrument, Amount $2.00M.
- 2024-04-09: Debt Conversion, Converted Instrument, Amount $1.50M.
- 2023-03-15: Debt Conversion, Converted Instrument, Amount $1.00M.
- 2022-02-17: Debt Conversion, Converted Instrument, Amount $1.00M.
| Period end | Debt Conversion, Converted Instrument, Amount |
|---|---|
| 2024-08-28 | $2.00M 20-F · filed 2026-03-25 |
| 2024-04-09 | $1.50M 20-F · filed 2026-03-25 |
| 2023-03-15 | $1.00M 20-F · filed 2026-03-25 |
| 2022-02-17 | $1.00M 20-F · filed 2026-03-25 |